389 related articles for article (PubMed ID: 36339448)
1. The critical role of gut microbiota in obesity.
Cheng Z; Zhang L; Yang L; Chu H
Front Endocrinol (Lausanne); 2022; 13():1025706. PubMed ID: 36339448
[TBL] [Abstract][Full Text] [Related]
2. The microbiota-gut-brain axis in obesity.
Torres-Fuentes C; Schellekens H; Dinan TG; Cryan JF
Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):747-756. PubMed ID: 28844808
[TBL] [Abstract][Full Text] [Related]
3. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
Amabebe E; Robert FO; Agbalalah T; Orubu ESF
Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
[TBL] [Abstract][Full Text] [Related]
4. The Gut Microbiota: The Gateway to Improved Metabolism.
Martinez KB; Pierre JF; Chang EB
Gastroenterol Clin North Am; 2016 Dec; 45(4):601-614. PubMed ID: 27837775
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota in Obesity and Undernutrition.
de Clercq NC; Groen AK; Romijn JA; Nieuwdorp M
Adv Nutr; 2016 Nov; 7(6):1080-1089. PubMed ID: 28140325
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
[TBL] [Abstract][Full Text] [Related]
7. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications.
Cuevas-Sierra A; Ramos-Lopez O; Riezu-Boj JI; Milagro FI; Martinez JA
Adv Nutr; 2019 Jan; 10(suppl_1):S17-S30. PubMed ID: 30721960
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
Lee P; Yacyshyn BR; Yacyshyn MB
Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiome approaches to treat obesity in humans.
Bianchi F; Duque ALRF; Saad SMI; Sivieri K
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1081-1094. PubMed ID: 30554391
[TBL] [Abstract][Full Text] [Related]
10. Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress.
Lim YY; Lee YS; Ooi DSQ
Biotechnol J; 2020 Oct; 15(10):e2000013. PubMed ID: 32663372
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Gut Microbiota for Remediating Obesity and Related Metabolic Disorders.
Wang B; Wang L; Wang H; Dai H; Lu X; Lee YK; Gu Z; Zhao J; Zhang H; Chen W; Wang G
J Nutr; 2021 Jul; 151(7):1703-1716. PubMed ID: 33982127
[TBL] [Abstract][Full Text] [Related]
13. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?
Kapoor B; Gulati M; Gupta R; Singla RK
Autoimmun Rev; 2023 May; 22(5):103313. PubMed ID: 36918089
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota: a target for intervention in obesity.
Sehgal K; Khanna S
Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
17. Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice.
de Sant'Ana LP; Ribeiro DJS; Martins AMA; Dos Santos FN; Corrêa R; Almeida RDN; Eberlin MN; Maurice CF; Magalhães KG
Front Immunol; 2019; 10():2926. PubMed ID: 31998283
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal involvement of autism spectrum disorder: focus on gut microbiota.
Settanni CR; Bibbò S; Ianiro G; Rinninella E; Cintoni M; Mele MC; Cammarota G; Gasbarrini A
Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):599-622. PubMed ID: 33356668
[TBL] [Abstract][Full Text] [Related]
19. Obesity and gut-microbiota-brain axis: A narrative review.
Asadi A; Shadab Mehr N; Mohamadi MH; Shokri F; Heidary M; Sadeghifard N; Khoshnood S
J Clin Lab Anal; 2022 May; 36(5):e24420. PubMed ID: 35421277
[TBL] [Abstract][Full Text] [Related]
20. The gut microbiota as a therapeutic target for obesity: a scoping review.
Santos-Paulo S; Costello SP; Forster SC; Travis SP; Bryant RV
Nutr Res Rev; 2022 Dec; 35(2):207-220. PubMed ID: 34100344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
